Gilberto Fronza
0000-0003-3722-553X
IRCCS Ospedale Policlinico San Martino
2 papers found
Refreshing results…
Validation of a survival-risk score (SRS) in relapsed/refractory CLL patients treated with idelalisib–rituximab
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcome
Missing publications? Search for publications with a matching author name.